Antitrust investigations typically signal regulatory concerns about a company's market power and business practices, which can lead to negative outcomes such as fines, restrictions, or forced divestitures. Given UnitedHealth's significant role in the healthcare sector, this investigation could have substantial implications for its operations and financial performance. The announcement of such an investigation often leads to negative investor sentiment in the short term, as the market assesses potential risks and uncertainties.